Genomics-led research is improving the diagnosis & treatment of rare diseases in Canada | #RareDiseaseDay2023

Genomics-led research is improving the diagnosis & treatment of rare diseases in Canada | #RareDiseaseDay2023

Did you know it’s #RareDiseaseDay2023 – a day to raise awareness for people across the globe impacted by rare diseases???

Today, we’re sharing a few of the many stories of Canadians with rare diseases whose lives have been transformed by genomics-enabled precision health. Explore below.

Laurent's story

Laurent Tessier, his mom, and his dog.

Four letters that save lives: A,C,G & T

Diagnosing a rare disease can be a long, confusing journey for patients and families. No one understands this journey better than Laurent Tessier, 17, who survived an aggressive cancer thanks to a genomics research program at Montreal's CHU Sainte-Justine.

Read Laurent's full story here.

Anna's story

Anna and her mom, Mallory Boileau.

All for One: Making Anna Boileau's 12-year wait for a diagnosis a thing of the past

Anna Boileau spent the first 12 years of her life in and out of hospitals as health professionals struggled to diagnose her rare disease. In this article, Anna's mom, Mallory Boileau, shares her daughter's journey to a diagnosis and the impact that increased access to genomic-sequencing will have for Canadians.?

Read Anna's full story here.

Sienna's story

Sienna drawing.

The promise of precision health: Sienna's story

12-year-old Sienna, a rare disease patient from Kingston, Ontario, has a rare form of epilepsy that affects her daily life. Genomics research works to provide children, like Sienna, with the diagnosis and treatment they need, and offer hope with the future of precision health treatment.??

Watch Sienna’s full story here.??

Q&A with Dr. Victor Martinez?

Dr. Victor Martinez.

Improving treatment and diagnosis in Atlantic Canada?

At the heart of our All For One precision health initiative are six implementation projects located across Canada. In this article, Dr. Victor Martinez discusses how precision health projects will impact Atlantic Canada and enable a new standard of care for rare disease patients.??

Read the full Q&A here.??


Genome Canada’s All for One initiative is enabling a new standard of care for Canadians with rare genetic diseases. Learn more.

要查看或添加评论,请登录

社区洞察